Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration

A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives

(2022) Peng Liu et al.   MOLECULES

Characterization of nanoparticles-based vaccines for COVID-19

(2022) Giuditta Guerrini et al.   Nature Nanotechnology

Pfizer's vaccine raises allergy concerns

(2021) Jop de Vrieze   SCIENCE

Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine

(2021) Priya Sellaturay et al.   CLINICAL AND EXPERIMENTAL ALLERGY

mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability

(2021) Linde Schoenmaker et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines

(2021) Kimberly A. Risma et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Vaccine allergy

(2021) Lennart Nilsson et al.   Current Opinion in Allergy and Clinical Immunology

Allergic Reactions to mRNA Vaccines

(2021) Rita Rubin   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Lipid nanoparticles for mRNA delivery

(2021) Xucheng Hou et al.   Nature Reviews Materials

Pseudo-Anaphylactic Reactions to Pfizer BNT162b2 Vaccine: Report of 3 Cases of Anaphylaxis Post Pfizer BNT162b2 Vaccination

(2021) Xin Rong Lim et al.   Vaccines

The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines

(2021) P. Bigini et al.   Nature Nanotechnology

Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine

(2021) Annalisa Ciabattini et al.   Frontiers in Immunology

The Slower Antibody Response in Myelofibrosis Patients after Two Doses of mRNA SARS-CoV-2 Vaccine Calls for a Third Dose

(2021) Fabio Fiorino et al.   Biomedicines

Anti-PEG antibodies: Properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals

(2020) Gergely Tibor Kozma et al.   ADVANCED DRUG DELIVERY REVIEWS

PEGylated biologics in haemophilia treatment: Current understanding of their long‐term safety

(2019) Andreas Baumann   HAEMOPHILIA

Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized

(2018) Cosby A. Stone et al.   Journal of Allergy and Clinical Immunology-In Practice

Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population

(2016) Qi Yang et al.   ANALYTICAL CHEMISTRY

Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals

(2016) Bing-Mae Chen et al.   ANALYTICAL CHEMISTRY

Editorial overview: Vaccines: novel technologies for vaccine development

(2016) Rino Rappuoli et al.   CURRENT OPINION IN IMMUNOLOGY

PEGylation of Biopharmaceuticals: A Review of Chemistry and Nonclinical Safety Information of Approved Drugs

(2016) Peter L. Turecek et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Vaccine Refusal, Mandatory Immunization, and the Risks of Vaccine-Preventable Diseases

(2009) Saad B. Omer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical trial: single- and multiple-dose pharmacokinetics of polyethylene glycol (PEG-3350) in healthy young and elderly subjects

(2008) R. W. PELHAM et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS